What is the significance of a hypoechoic area on an ultrasound?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Article Review Status
Submitted
Under Review
Approved

Last updated: April 22, 2025 • View editorial policy

From the Guidelines

A hypoechoic area on ultrasound should be further evaluated with additional imaging studies, such as contrast-enhanced ultrasound, CT scan, or MRI, to determine its clinical significance and potential causes, including fluid-filled structures, solid masses, inflammation, or normal anatomical structures with low echogenicity. The presence of a hypoechoic area can indicate various conditions, and its interpretation depends on the location, size, shape, borders, and the patient's symptoms and medical history 1. According to the most recent guidelines, biliary hamartomas, for example, may appear as hypoechoic, hyperechoic, or mixed heterogenic echoic structures on ultrasound, with characteristic "comet-tail" artifacts and a typical size between 2 to 10 mm 1.

When evaluating a hypoechoic area, it is essential to consider the patient's risk factors, such as cirrhosis, and the potential for hepatocellular carcinoma (HCC), which can also present as a hypoechoic lesion on ultrasound 2. In patients with cirrhosis, any nodule larger than 1 cm should be considered an abnormal screening result warranting further investigation, as the majority of nodules smaller than 1 cm are not HCC 2.

The next steps in management would depend on the results of the additional imaging studies and the patient's overall clinical picture. In some cases, a biopsy might be recommended to determine if the area contains abnormal cells. The clinical significance of a hypoechoic area can only be determined by a qualified healthcare provider who can interpret the findings in the context of the complete clinical picture.

Some possible causes of hypoechoic areas on ultrasound include:

  • Fluid-filled structures, such as cysts or abscesses
  • Solid masses, such as tumors (benign or malignant)
  • Inflammation
  • Normal anatomical structures with low echogenicity, such as certain muscles or organs
  • Biliary hamartomas, which can appear as hypoechoic, hyperechoic, or mixed heterogenic echoic structures on ultrasound 1.

In patients with cirrhosis, it is crucial to follow surveillance guidelines, which recommend ultrasonography as the primary screening method, with screening intervals of 6 to 12 months 2. Early detection and characterization of hypoechoic areas on ultrasound are critical for determining the appropriate management and improving patient outcomes.

From the Research

Hypoechoic Area on Ultrasound

  • A hypoechoic area on ultrasound refers to an area that appears less echogenic or darker than the surrounding tissue 3.
  • The differential diagnosis of hypoechoic lesions comprises a large variety of benign and malignant diseases or abnormalities, including solid or cystic masses in the abdomen 3.
  • In the context of gallbladder tumors, a hypoechoic area may represent an adenocarcinoma invading the subserosa accompanied by abundant fibrosis 4.

Causes of Hypoechoic Areas

  • Hypoechoic areas can be caused by various factors, including: + Necrosis or metastatic hemorrhages in lymph nodes 5 + Suppuration in inflamed lymph nodes 5 + Abundant fibrosis in gallbladder tumors 4 + Mucosal defects or thickening in the stomach 6

Ultrasound Characteristics

  • Hypoechoic areas can appear as anechoic or hypoechoic regions within a lymph node or other tissue 5
  • The ultrasound characteristics of hypoechoic areas can be similar to those of other pathologies, making diagnosis challenging 5
  • Color Doppler ultrasound can be used to evaluate blood flow signals in hypoechoic areas, but may not always demonstrate enlarged intrathyroidal vessels or hypervascularity 7

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.